chr4-55396043-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000381334.10(TMEM165):c.-147T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00939 in 555,812 control chromosomes in the GnomAD database, including 250 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.027 ( 209 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 41 hom. )
Consequence
TMEM165
ENST00000381334.10 5_prime_UTR
ENST00000381334.10 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0410
Genes affected
TMEM165 (HGNC:30760): (transmembrane protein 165) This gene encodes a predicted transmembrane protein with a perinuclear Golgi-like distribution in fibroblasts. Mutations in this gene are associated with the autosomal recessive disorder congenital disorder of glycosylation, type IIk. Knockdown of this gene's expression causes decreased sialylation in HEK cells and suggests this gene plays a role in terminal Golgi glycosylation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 4-55396043-T-C is Benign according to our data. Variant chr4-55396043-T-C is described in ClinVar as [Benign]. Clinvar id is 907295.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0923 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM165 | NM_018475.5 | c.-147T>C | 5_prime_UTR_variant | 1/6 | ENST00000381334.10 | NP_060945.2 | ||
TMEM165 | XM_011534394.4 | c.-147T>C | 5_prime_UTR_variant | 1/6 | XP_011532696.1 | |||
TMEM165 | XM_017008412.2 | c.-592T>C | 5_prime_UTR_variant | 1/8 | XP_016863901.1 | |||
TMEM165 | NR_073070.2 | n.87T>C | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM165 | ENST00000381334.10 | c.-147T>C | 5_prime_UTR_variant | 1/6 | 1 | NM_018475.5 | ENSP00000370736 | P1 | ||
TMEM165 | ENST00000506198.5 | c.-147T>C | 5_prime_UTR_variant | 1/3 | 2 | ENSP00000425449 | ||||
TMEM165 | ENST00000508404.5 | c.-147T>C | 5_prime_UTR_variant, NMD_transcript_variant | 1/7 | 2 | ENSP00000422639 |
Frequencies
GnomAD3 genomes AF: 0.0273 AC: 4149AN: 152012Hom.: 209 Cov.: 32
GnomAD3 genomes
AF:
AC:
4149
AN:
152012
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00264 AC: 1065AN: 403692Hom.: 41 Cov.: 6 AF XY: 0.00202 AC XY: 412AN XY: 203740
GnomAD4 exome
AF:
AC:
1065
AN:
403692
Hom.:
Cov.:
6
AF XY:
AC XY:
412
AN XY:
203740
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0273 AC: 4153AN: 152120Hom.: 209 Cov.: 32 AF XY: 0.0262 AC XY: 1948AN XY: 74360
GnomAD4 genome
AF:
AC:
4153
AN:
152120
Hom.:
Cov.:
32
AF XY:
AC XY:
1948
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
TMEM165-congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 06, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at